Related Experiment Video
Updated: Jun 27, 2026
13:36
Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
Recent approaches in hantavirus vaccine development.
Piet Maes1, Jan Clement, Marc Van Ranst
1Clinical Virology, Rega Institute for Medical Research, Katholieke Universiteit Leuven, Minderbroedersstraat 10, B3000 Leuven, Belgium. pmaes3@uzleuven.be
Expert Review of Vaccines
|December 20, 2008
Summary
Hantaviruses cause severe diseases like hemorrhagic fever with renal syndrome and hantavirus cardiopulmonary syndrome. This review covers current and novel strategies for developing effective hantavirus vaccines, as none are widely accepted.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- Hantaviruses, transmitted by rodents, cause severe human diseases including hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS).
- Despite the life-threatening nature of hantavirus infections, effective antiviral treatments are lacking.
- Current vaccine candidates have not achieved widespread acceptance by the World Health Organization (WHO).
Purpose of the Study:
- To review existing knowledge on hantavirus vaccines.
- To summarize recent advancements in hantavirus vaccine development.
- To explore novel and speculative approaches for future vaccine design.
Main Methods:
- Literature review of published research on hantavirus vaccines.
- Analysis of current progress in preclinical and clinical vaccine studies.
- Discussion of emerging vaccine technologies and strategies.
Main Results:
- No specific antiviral therapy is currently available for hantavirus infections.
- Existing hantavirus vaccines face challenges in achieving widespread WHO approval.
- Several promising research avenues and speculative approaches are being explored for vaccine development.
Conclusions:
- There is an urgent need for effective hantavirus vaccines.
- Continued research into diverse vaccine platforms is crucial.
- Novel strategies may overcome current limitations in hantavirus vaccine development.
